1. Home
  2. LXEO vs SAMG Comparison

LXEO vs SAMG Comparison

Compare LXEO & SAMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • SAMG
  • Stock Information
  • Founded
  • LXEO 2017
  • SAMG 2002
  • Country
  • LXEO United States
  • SAMG United States
  • Employees
  • LXEO N/A
  • SAMG N/A
  • Industry
  • LXEO
  • SAMG Investment Managers
  • Sector
  • LXEO
  • SAMG Finance
  • Exchange
  • LXEO Nasdaq
  • SAMG Nasdaq
  • Market Cap
  • LXEO 140.6M
  • SAMG 170.2M
  • IPO Year
  • LXEO 2023
  • SAMG 2013
  • Fundamental
  • Price
  • LXEO $2.97
  • SAMG $16.83
  • Analyst Decision
  • LXEO Strong Buy
  • SAMG
  • Analyst Count
  • LXEO 5
  • SAMG 0
  • Target Price
  • LXEO $23.80
  • SAMG N/A
  • AVG Volume (30 Days)
  • LXEO 475.1K
  • SAMG 19.7K
  • Earning Date
  • LXEO 03-18-2025
  • SAMG 03-06-2025
  • Dividend Yield
  • LXEO N/A
  • SAMG 4.75%
  • EPS Growth
  • LXEO N/A
  • SAMG 4.17
  • EPS
  • LXEO N/A
  • SAMG 1.00
  • Revenue
  • LXEO N/A
  • SAMG $123,651,000.00
  • Revenue This Year
  • LXEO N/A
  • SAMG $7.46
  • Revenue Next Year
  • LXEO N/A
  • SAMG $6.36
  • P/E Ratio
  • LXEO N/A
  • SAMG $16.84
  • Revenue Growth
  • LXEO N/A
  • SAMG 5.32
  • 52 Week Low
  • LXEO $2.32
  • SAMG $13.93
  • 52 Week High
  • LXEO $19.50
  • SAMG $19.20
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 37.57
  • SAMG 32.62
  • Support Level
  • LXEO $2.51
  • SAMG $16.95
  • Resistance Level
  • LXEO $2.95
  • SAMG $18.19
  • Average True Range (ATR)
  • LXEO 0.34
  • SAMG 0.51
  • MACD
  • LXEO 0.07
  • SAMG -0.12
  • Stochastic Oscillator
  • LXEO 40.88
  • SAMG 3.27

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

Share on Social Networks: